Virological Response in Patients with Hepatitis C Virus Genotype 1b and a High Viral Load: Impact of Peginterferon-α-2a plus Ribavirin Dose Reductions and Host-Related Factors

Author： Yamada Gotaro  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.28, Iss.1, 2008-01, pp. : 9-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon- -2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1

By Buti Maria  

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1043-1055

Adis International

Access to resources Recommend Favorite

Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines

By Siebert Uwe   Sroczynski Gaby   Aidelsburger Pamela  

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 341-354

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2b/ribavirin: Falsely low HbA1c levels (first report with peginterferon-α-2b): case report

By  

Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2b/ribavirin: Autoimmune hepatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1204, 2008-01 ,pp. : 25-26

Adis International

Access to resources Recommend Favorite

Peginterferon-α-2a + ribavirin: shorter treatment duration inferior in hepatitis C

By  

Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite